Immutep announce it has received a EUR 2,194,918 research and development tax incentive payment in cash from the French Government under its Credit d’Impot Recherche scheme, CIR. The “Credit d’Impot Recherche”, meaning “Research Tax Credit”, is a French government tax incentive by which French companies conducting research and development activities in Europe can be reimbursed 30% of their eligible expenditure.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMMP:
- Immutep announces new data from EFTISARC-NEO
- Immutep’s Efti Shows Promise in Cancer Therapy
- Immutep announces efficacy, safety results from TACTI-003 Phase IIb trial
- Immutep’s Efti in Combination with MSD’s KEYTRUDA® Leads to Positive Efficacy with Favourable Safety in First Line Head and Neck Cancer
- Immutep: Quarterly Rebalance of S&P/ASX Indices